Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients: A Brief Report

@article{Nisman2014SerumTK,
  title={Serum Thymidine Kinase 1 Activity in the Prognosis and Monitoring of Chemotherapy in Lung Cancer Patients: A Brief Report},
  author={Benjamin Nisman and Hovav Nechushtan and Haim Biran and Hadas Gantz-Sorotsky and Nir Peled and Simon Gronowitz and Tamar Peretz},
  journal={Journal of Thoracic Oncology},
  year={2014},
  volume={9},
  pages={1568–1572}
}
Introduction: Thymidine kinase 1 (TK1) is a metabolic enzyme involved in DNA synthesis. Most standard treatment protocols for lung cancer (LC) include cytotoxic agents, which are potential modulators of TK1. We aimed to assess the prognostic significance of serum TK1 activity and its role in monitoring chemotherapy in LC patients. Methods: TK1 activity was measured using the DiviTum (Biovica) assay in sera from 233 patients with non–small-cell lung cancer (NSCLC), 91 with small-cell lung cancer… 

Thymidine kinase 1 in serum for prognosis, an investigation on routine individual adapted treatment of non-small cell lung carcinoma.

TLDR
STK1p correlates significantly to survival and is an independent multivariate prognostic factor in NSCLC patients, and is a useful tool to combine with imager for a rational approach to increase the efficacy in early detection of tumor in lung cancer screening and assessment of individual adjusted therapy in NSClC patients.

Serum Concentration of Thymidine Kinase 1 (TK1) as a Tumor Marker in Soft Tissue Sarcomas

TLDR
TK1 has limited use as a tumor marker in localized STS, and there is no association between increased preoperative TK1 and age, sex, tumor size, grade, and the presence of vascular invasion or necrosis.

Thymidine kinase 1 through the ages: a comprehensive review

TLDR
Compared to other proliferation markers, TK1 levels during S phase more accurately determine the rate of DNA synthesis in actively dividing tumors, and is potentially more advantageous than current biomarkers.

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer

The rapid development of new therapies in metastatic breast cancer (MBC), entails a need for improved prognostic and monitoring tools. Thymidine kinase 1 (TK1) is involved in DNA synthesis and its

Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer

TLDR
Pancreatic ductal adenocarcinomas reveal a significant increase in S-TK activity, which is associated with overall survival, especially in early tumor stages, and may be a useful parameter for monitoring nTx efficacy.

Serum thymidine kinase 1 levels correlate with clinical characteristics of esophageal squamous cell carcinoma.

TLDR
The correlation of serum TK1 levels with clinical features of esophageal cancer and with patient survival suggest that serum Tk1 may serve as a valuable biomarker for predicting patient prognosis.

Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy

TLDR
It is suggested that TK1 could be a potential prognostic, predictive and monitoring marker of early ET response in HR+/HER2neg MBC patients.

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

TLDR
Serum TK1 activity is a promising pharmacodynamic marker of palbociclib in ER+ breast cancer, and its value in predicting response to CDK4/6 inhibitors warrants further investigation.

Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

TLDR
The study demonstrated that lower baseline levels of all three TM were associated with higher probability of complete or partial remission, and the statistical difference was higher.

Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy

TLDR
This study demonstrates the clinical validity of pTKa as a new circulating prognostic marker in ER+/HER2− MBC patients treated with endocrine therapy and palbociclib and significantly improved survival prediction.

References

SHOWING 1-10 OF 16 REFERENCES

Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer.

TLDR
Although the performance of serum TK for diagnosis and therapy monitoring of advanced lung cancer was poor, it has a promising prognostic relevance which will have to be further validated.

Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer

  • T. KorkmazS. Seber N. Turhal
  • Medicine, Biology
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
  • 2013
TLDR
The magnitude of maximum fluorodeoxyglucose uptake in primary tumors and the serum TK1 level in patients with metastatic NSCLC were found to be independent prognostic predictors of overall survival.

Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy.

TLDR
Thymidine kinase seems to be a suitable parameter for monitoring the effect of adjuvant and palliative chemotherapy in colorectal cancer.

Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients

TLDR
Two recently developed immunoassays for serum thymidine kinase 1 (TK1) activity, DiviTum and Liaison, may be used for recurrence prediction in preoperative evaluation of BC patients.

Contribution of Thymidylate Synthase to Gemcitabine Therapy for Advanced Pancreatic Cancer

TLDR
The expression of TS provides an alternative source of substrate for DNA synthesis and positively correlates with GEM resistance and shortened patient survival.

Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions

TLDR
The literature surrounding hENT1 in pancreatic cancer is synthesized, the key outstanding questions are identified, and strategies to prospectively evaluate the clinical utility of hent1 in future clinical studies are suggested.

Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers

TLDR
It is concluded that the scores for PCNA and Ki67 antigen, immunohistochemically detected in ethanol fixed, paraffin embedded tissue reflect functional proliferative activity.

Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514.

TLDR
The data demonstrate that inhibition of thymidylate synthase is a prominent mechanism for antitumor activity by LY231514, but important secondary sites of action exist for this multitargeted molecule.

Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression.

TLDR
Data suggest that TK activity and NT expression have a common regulatory mechanism which is sensitive to endogenous dTTP pools and that the salvage pathway is a complex system of kinases coordinated with transport of nucleosides.

Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents.

TLDR
Etoposide is identified as a potent inducer for ENT1 activity and [(3)H]FLT uptake and requests caution for the application of ENT1-mediated [(18)F] FLT flare for treatment monitoring.